HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

'Free Trial' Plus False Claims Equals More FTC Enforcement In Supplement Market

This article was originally published in The Rose Sheet

Executive Summary

FTC on consecutive days announced court order closing a California business allegedly charging consumers for products and enrolling them in negative-option continuity plans without their consent after they responded to bogus free trial online offers, and started mailing 16,596 checks totaling more than $750,000 to consumers who bought deceptively marketed supplements from a Maine firm that also lured customers with a free trial pitch.

You may also be interested in...



Health Market News: Acetaminophen Prop 65 Report Posted; Loperamide Brands' Smaller Packaging

Brand-name loperamide OTCs will be packaged in single doses with no more than 48 mg per container; and California posts acetaminophen hazard identification for Prop 65 consideration.

Wellness Market News: Herbal Product Sales Jump; FTC Expects $6M From 'Free Trial' Supplement Marketers

US herbal supplement sales' growth in 2018 was strongest since 1998, says American Botanical Council's Herb Market Report; and principals of Apex Capital Group and 12 businesses they controlled agree to orders settling FTC's allegations.

FTC's Claimed Authority To Chase Permanent Injunctions, Monetary Relief May Lack Substantiation

The Federal Trade Commission has long held that Section 13(b) of the FTC Act authorizes the agency to seek permanent injunctions against, and monetary relief from, alleged violators of consumer protection provisions. But that understanding is being put to the test, and cracks are beginning to show, attorneys say.

Related Content

Topics

UsernamePublicRestriction

Register

RS122550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel